cell based therapeutic composed of allogeneic donor apoptotic cells

cell based therapeutic composed of allogeneic donor apoptotic cells
Trade Name Apocell
Orphan Indication Graft Versus Host Disease
USA Market Approval USA
USA Designation Date 2013-03-18 00:00:00
Sponsor Enlivex Therapeutics Ltd.;POB 12167, Hadassah Ein Kerem;Jerusalem